Teijin Company Description

Teijin Limited engages in the fibers, films and sheets, composites, healthcare, and IT businesses worldwide.

It offers aramid fibers; glass and carbon fibers, composite materials, and oxidized PAN fibers; polycarbonate sheets and films; high-density polyethylene porous films and materials; and microporous films.

The company also provides PC resins, polyphenylene sulfide resins, molded parts, and additives; lightweight glass and carbon fiber reinforced composites for automotive applications; and polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers.

In addition, it offers pharmaceuticals for bone and joint, respiratory, cardiovascular and metabolic, and other diseases; home oxygen therapy, non-invasive positive pressure ventilation, and sleep disordered breathing related devices, as well as sonic accelerated fracture healing system and community-based integrated care system businesses.

Further, the company provides implantable medical devices and regenerative medical products. Additionally, it develops and implements engineering solutions for various issues, such as environmental pollution, energy supply stability, and aging-related workforce population decline.

Teijin Limited was incorporated in 1918 and is headquartered in Tokyo, Japan.

Teijin Limited

Country	Japan
Founded	1918
Industry	Conglomerates
Sector	Industrials
Employees	20,279
CEO	Akimoto Uchikawa

Contact Details

Address: Kasumigaseki Common Gate West Tower Tokyo, 100-8585 Japan
Phone	81 3 3506 4529
Website	teijin.com

Stock Details

Ticker Symbol	3401
Exchange	Tokyo Stock Exchange
Stock Type	Common Stock
Fiscal Year	April - March
Reporting Currency	JPY
ISIN Number	JP3544000007
SIC Code	2820

Key Executives

Name	Position
Akimoto Uchikawa	Chief Executive Officer
Naohiko Moriyama	Chief Financial Officer
Naoki Hamashima	Head of Investor Relations